Published in Vaccine Weekly, March 29th, 2000
"Determination of circulating antibodies against tumor neoantigens is important for the development of preventive or therapeutic vaccines," noted R. Pasquinelli and colleagues from the Istituto Internazionale di Genetica e Biofisica, Italy. "We report here the finding of antibodies against the breast tumor antigen GCDFP-15/gp17."
Pasquinelli et al. presented data from their study at the 1st International Conference and 5th Annual Meeting of the International Society of Cancer Chemoprevention: Tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.